Zachary Collins
Papers
1
Total Citations
30
H-Index
1
About
Zachary Collins is a pioneering researcher in interventional oncology, with a primary focus on non-invasive tumor ablation technologies. His most significant contribution is his leadership in the #HOPE4LIVER single-arm pivotal trial, which evaluated histotripsy—a groundbreaking non-thermal, noninvasive focused ultrasound therapy—for primary and metastatic liver tumors. This innovative approach mechanically liquefies targeted tissue at the focal point of a transducer, offering a paradigm shift from traditional thermal ablation methods. The 2025 publication of this trial, already garnering 30 citations, demonstrates the immediate and substantial impact of his work on the field. Collins’ research addresses a critical need for safer, more precise treatments for liver malignancies, potentially reducing complications associated with surgery and thermal ablation. By validating histotripsy’s clinical efficacy, he has positioned himself at the forefront of ultrasound-mediated therapies, paving the way for broader adoption of this technology in oncologic care. His work not only advances technical frontiers but also offers new hope for patients with challenging liver tumors.
Research Focus
Key Achievements
Top Papers
- 1